Brian DeSchuytner insider trades

Open-market stock purchases and sales by Brian DeSchuytner, SVP, COO & CFO at Mersana Therapeutics, Inc, from SEC Form 4 filings since Jul 10, 2019.

Recent trades

DateStockTradeValue
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$27.4K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$411K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$172K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$711K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$967K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$81.3K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$56.3K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$124K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$2.2M
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$44.1K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$662K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$124K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$400K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$558K

Companies traded

  • MRSN Mersana Therapeutics, Inc: 7 sales, last Jan 6, 2026

Get free alerts when Brian DeSchuytner files a new trade →